Philips and Reinier de Graaf Hospital Expand Existing Strategic Partnership

PhilipsRoyal Philips N.V. (NYSE: PHG, AEX: PHIA) and the 622-bed Reinier de Graaf hospital (Delft, the Netherlands) have announced the signing of an additional 15-year partnership agreement. The agreement, which will give the entire hospital long-term continuous access to Philips' advanced diagnostic and interventional ultrasound technologies, represents a significant extension of an existing multi-year partnership entered into in September 2014. Being the most extensive and holistic agreement for ultrasound ever signed by Philips in the Netherlands, this new agreement emphasizes Philips' global technology leadership in medical ultrasound as well as its role as an accountable business partner.

The new agreement applies to all of the hospital's departments and sites, including a new principal site that will open in August of this year. This latest generation of ultrasound systems being supplied as part of the agreement will offer simplified workflows and a powerful combination of speed and image clarity. The systems will be used, among other applications, for abdominal examinations and for examinations during pregnancy, but will also play an important role in the treatment of rheumatism and the image-guided treatment of patients with cardiovascular disease, performed using the latest live 3D imaging technologies.

This next step in the collaboration between Reinier de Graaf hospital and Philips marks a substantial expansion of the existing partnership between Philips and Reinier de Graaf. The existing partnership already gives the hospital fast and continuous access to the latest diagnostic and interventional imaging systems and clinical informatics solutions as well as innovative planning and consultancy services to help improve the quality and efficiency of healthcare provision. With current and future health care developments in mind, flexibility is one of the core elements of this partnership, enabling the optimal level of patient care and operational efficiency.

Working with a single family of ultrasound systems, all with similar interfaces and usability, hospital personnel will soon be able to work with ultrasound more easily and more efficiently. Ultrasound systems will be easily interchangeable between healthcare professionals and departments - for example, when additional capacity or functionality is needed. Training hospital personnel will also be more efficient.

"Reinier de Graaf carefully considered which ultrasound systems will be required after the move to our new hospital site," said Jaap van den Heuvel, CEO Reinier de Graaf hospital. "We firmly believe that we now have a balanced package that will enable every department to offer the required ultrasound diagnostics. Thanks to this partnership collaboration with Philips, we will now be able to tailor our equipment in a flexible way to suit future developments."

"Philips is changing from a supplier of medical technology to a service provider that supports hospitals across the healthcare continuum, both in terms of the quality of healthcare and in terms of performance and efficiency," said Henk Valk, General Manager of Philips Healthcare Benelux. "We are finding that hospitals are increasingly opting for this strategic partnership model. The new agreement with the Reinier de Graaf hospital shows how, through partnerships like these and the experiences and the relationship of trust that arise from them, we are able to explore additional areas where we can deliver added value for one another."

The new ultrasound systems will be operational with effect from May of this year. Philips is a global leader in medical ultrasound. Thanks to its cost-effectiveness and flexibility, ultrasound is one of the fastest-growing imaging modalities in the market. With its technology leadership, Philips has been able to build a broad and complete portfolio of ultrasound solutions for both diagnostics and interventional therapy.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 108,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Almost All Leading AI Chatbots Show Sign…

Almost all leading large language models or "chatbots" show signs of mild cognitive impairment in tests widely used to spot early signs of dementia, finds a study in the Christmas...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...

AI-Based Chatbot Created for Bioimage An…

Scientists from Universidad Carlos III de Madrid (UC3M), together with a research team from Ericsson and the KTH Royal Institute of Technology in Sweden, have developed an artificial intelligence-based software...

Analyzing Multiple Mammograms Improves B…

A new study from Washington University School of Medicine in St. Louis describes an innovative method of analyzing mammograms that significantly improves the accuracy of predicting the risk of breast...

Emotional Cognition Analysis Enables Nea…

A joint research team from the University of Canberra and Kuwait College of Science and Technology has achieved groundbreaking detection of Parkinson's disease with near-perfect accuracy, simply by analyzing brain...